Argentina Glioblastoma Multiforme Treatment Market Size & Outlook
Related Markets
Argentina glioblastoma multiforme treatment market highlights
- The Argentina glioblastoma multiforme treatment market generated a revenue of USD 27.7 million in 2025 and is expected to reach USD 47.5 million by 2033.
- The Argentina market is expected to grow at a CAGR of 7% from 2026 to 2033.
- In terms of segment, surgery was the largest revenue generating treatment in 2025.
- Tumor Treating Field (TTF) Therapy is the most lucrative treatment segment registering the fastest growth during the forecast period.
Glioblastoma multiforme treatment market data book summary
| Market revenue in 2025 | USD 27.7 million |
| Market revenue in 2033 | USD 47.5 million |
| Growth rate | 7% (CAGR from 2026 to 2033) |
| Largest segment | Surgery |
| Fastest growing segment | Tumor Treating Field (TTF) Therapy |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy (Bevacizumab), Tumor Treating Field (TTF) Therapy |
| Key market players worldwide | Merck & Co Inc, Amgen Inc, Roche, Pfizer Inc, Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries, Arbor Pharmaceuticals, Amneal Pharmaceuticals, Karyopharm Therapeutics Inc, Sumitomo Dainippon Pharma Oncology |
Other key industry trends
- In terms of revenue, Argentina accounted for 0.7% of the global glioblastoma multiforme treatment market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Latin America, Brazil glioblastoma multiforme treatment market is projected to lead the regional market in terms of revenue in 2033.
- Brazil is the fastest growing regional market in Latin America and is projected to reach USD 162.7 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Glioblastoma Multiforme Treatment Market Scope
Glioblastoma Multiforme Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Sumitomo Dainippon Pharma Oncology | View profile | 251-500 | Cambridge, Massachusetts, United States, North America | https://www.sdponcology.com/ |
| Amneal Pharmaceuticals | View profile | 5001-10000 | Bridgewater, New Jersey, United States, North America | http://amneal.com/ |
| Arbor Pharmaceuticals | View profile | 501-1000 | Atlanta, Georgia, United States, North America | http://www.arborpharma.com |
| Karyopharm Therapeutics Inc | View profile | 325 | 85 Wells Avenue, 2nd Floor, Newton, MA, United States, 02459 | https://www.karyopharm.com |
| Roche | View profile | 10001+ | Basel, Basel-Stadt, Switzerland, Europe | http://www.roche.com |
| Sun Pharmaceutical Industries | View profile | 10001+ | Mumbai, Maharashtra, India, Asia | http://www.sunpharma.com |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Amgen Inc | View profile | 26700 | One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 | https://www.amgen.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
Argentina glioblastoma multiforme treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to glioblastoma multiforme treatment market will help companies and investors design strategic landscapes.
Surgery was the largest segment with a revenue share of 33.21% in 2025. Horizon Databook has segmented the Argentina glioblastoma multiforme treatment market based on surgery, radiation therapy, chemotherapy, targeted therapy (bevacizumab), tumor treating field (ttf) therapy covering the revenue growth of each sub-segment from 2021 to 2033.
The glioblastoma multiforme treatment market in Argentina was valued at USD 13.61 million and In Argentina, high-grade gliomas are frequently reported as malignant tumors in adults and the standard of treatment involves surgery & chemoradiation. The health system of Argentina is complex with high inequality. Some of the people in the country receive highquality healthcare services while others face difficulty accessing primary care.
One of the major advancements in the oncology sector in Argentina was the establishment of National Cancer Institute, which works to reduce cancer mortality in the country while improving the quality of life of cancer patients. It is also responsible for conducting cancer research in the country. Thus, such government initiatives for the betterment of cancer treatment in the country and growing awareness about rare cancer may potentially create moderate to good opportunities for market growth.
Reasons to subscribe to Argentina glioblastoma multiforme treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Argentina glioblastoma multiforme treatment market databook
-
Our clientele includes a mix of glioblastoma multiforme treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Argentina glioblastoma multiforme treatment market , including forecasts for subscribers. This country databook contains high-level insights into Argentina glioblastoma multiforme treatment market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Argentina glioblastoma multiforme treatment gbm market size, by treatment, 2021-2033 (US$M)
Argentina Glioblastoma Multiforme Treatment Market Outlook Share, 2025 & 2033 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
